Raloxifene D4

Raloxifene D4
Product Description

Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist.;Labeled Raloxifene, intended for use as an internal standard for the quantification of Raloxifene by GC- or LC-mass spectrometry.

CLEARSYNTH LABS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy
Specifications
  • CAS Registry Number
    1185076-44-1

CLEARSYNTH LABS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy

More Products from CLEARSYNTH LABS LIMITED (42)

  • Clopidogrel D3 Hydrochloride

    Product Clopidogrel D3 Hydrochloride

    Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry.
  • Clopidogrel D3 Hydrogen sulphate

    Product Clopidogrel D3 Hydrogen sulphate

    Labeled Clopidogrel, intended for use as an internal standard for the quantification of Clopidogrel by GC- or LC-mass spectrometry.
  • Rilpivirine D6

    Product Rilpivirine D6

    Labeled Rilpivirine, intended for use as an internal standard for the quantification of Rilpivirine by GC- or LC-mass spectrometry.
  • Sildenafil D3

    Product Sildenafil D3

    Labeled Sildenafil, intended for use as an internal standard for the quantification of Sildenafil by GC- or LC-mass spectrometry.
  • Diatrizoic acid

    Product Diatrizoic acid

    Molecular formula: C11H9I3N2O4Molecular weight: 613.91
  • Dipyridamole D20

    Product Dipyridamole D20

    Selective inhibitor of phosphodiesterase V (PDE 5); potent coronary vasodilator drug; adenosine transport inhibitor; inhibitor of platelet aggregation.;Labeled Dipyridamole, intended for use as an internal standard for the quantification of Dipyridamole by GC- or LC-mass spectrometry.
  • 5-Hydroxy Propafenone Hydrochloride D5

    Product 5-Hydroxy Propafenone Hydrochloride D5

    Labeled Propafenone, intended for use as an internal standard for the quantification of Propafenone by GC- or LC-mass spectrometry.
  • Raloxifene Hydrochloride

    Product Raloxifene Hydrochloride

    A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic.
  • Tolterodine D14 Hydrochloride

    Product Tolterodine D14 Hydrochloride

    Labeled Tolterodine, intended for use as an internal standard for the quantification of Tolterodine by GC- or LC-mass spectrometry.
  • (S)-Lercanidipine D3 Hydrochloride

    Product (S)-Lercanidipine D3 Hydrochloride

    A dihydropyridine calcium channel blocker.;Labeled Lercanidipine, intended for use as an internal standard for the quantification of Lercanidipine by GC- or LC-mass spectrometry.
  • Rac-Hydroxy Ezetimibe D4

    Product Rac-Hydroxy Ezetimibe D4

    Labeled Ezetimibe, intended for use as an internal standard for the quantification of Ezetimibe by GC- or LC-mass spectrometry.
  • 4-Hydroxy Atorvastatin D5 Disodium Salt

    Product 4-Hydroxy Atorvastatin D5 Disodium Salt

    A labeled metabolite of Atorvastatin,;Labeled Atorvastatin, intended for use as an internal standard for the quantification of Atorvastatin by GC- or LC-mass spectrometry.

CLEARSYNTH LABS LIMITED resources (1)

  • Video Clearsynth Intro Video

    Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.